PMID- 9949181 OWN - NLM STAT- MEDLINE DCOM- 19990311 LR - 20210216 IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 93 IP - 4 DP - 1999 Feb 15 TI - Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features. PG - 1372-80 AB - Conventional chromosome analysis (CCA) and interphase fluorescence in situ hybridization (FISH) was performed in 42 patients with mantle-cell lymphoma (MCL), with BCL1 rearrangement. The t(11;14)(q13;q32) or 11q abnormalities were detected by CCA in 34 cases, 20 of which had additional aberrations. A normal karyotype was observed in 8 cases. Probes detecting the chromosome aberrations that were observed in at least 3 cases by CCA, ie, +12, 13q14 deletion, and 17p deletion, were used for interphase FISH analysis. FISH detected total or partial +12, 13q14 deletion and 17p- in 28.5%, 52.4%, and 26% of the cases, respectively. The presence of these anomalies was not a function of karyotype complexity. Based on the results of CCA/FISH, three groups of increasing karyotype complexity were recognized: group 1, including 11 patients without detectable aberrations in addition to BCL1 rearrangement; group 2, including 14 patients with 1 to 2 additional anomalies; and group 3, including 17 patients with three or more additional anomalies. Clinical parameters associated with shorter survival were male sex (P =.006) and primary lymph-node involvement compared with primary bone marrow involvement (P =.015). Trisomy 12 was the only single cytogenetic parameter predictive of a poor prognosis (P =.006) and the best prognostic indicator was the derived measure of karyotype complexity (P <.0001), which maintained statistical significance in multivariate analysis (P<.0001). We arrived at the following conclusions: 13q14 deletion occurs at a high incidence in MCL; 17p deletion and total/partial +12 are relatively frequent events in MCL, the latter aberration being associated with a shorter survival; and the degree of karyotype complexity has a strong impact on prognosis in this neoplasia. FAU - Cuneo, A AU - Cuneo A AD - Department of Biomedical Sciences-Hematology Section, University of Ferrara, Italy. sse@dns.unife.it FAU - Bigoni, R AU - Bigoni R FAU - Rigolin, G M AU - Rigolin GM FAU - Roberti, M G AU - Roberti MG FAU - Bardi, A AU - Bardi A FAU - Piva, N AU - Piva N FAU - Milani, R AU - Milani R FAU - Bullrich, F AU - Bullrich F FAU - Veronese, M L AU - Veronese ML FAU - Croce, C AU - Croce C FAU - Birg, F AU - Birg F FAU - Dohner, H AU - Dohner H FAU - Hagemeijer, A AU - Hagemeijer A FAU - Castoldi, G AU - Castoldi G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Blood JT - Blood JID - 7603509 RN - 136601-57-5 (Cyclin D1) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Cell Lineage/*genetics MH - *Chromosomes, Human, Pair 11 MH - *Chromosomes, Human, Pair 14 MH - Cyclin D1/genetics MH - Female MH - Gene Rearrangement MH - Humans MH - Lymphoma/*genetics/*pathology MH - Male MH - Middle Aged MH - *Translocation, Genetic EDAT- 1999/02/09 00:00 MHDA- 1999/02/09 00:01 CRDT- 1999/02/09 00:00 PHST- 1999/02/09 00:00 [pubmed] PHST- 1999/02/09 00:01 [medline] PHST- 1999/02/09 00:00 [entrez] AID - S0006-4971(20)48776-2 [pii] PST - ppublish SO - Blood. 1999 Feb 15;93(4):1372-80.